BluSense Diagnostics is a dynamic MedTech company, a spin-off from the Technical University of Denmark. The company is developing a point-of-care blood testing device for infectious diseases, like dengue and Zika.

BluSense has a team of highly skilled professionals bringing together expertise in areas encompassing microfluidics, biochemistry, electronics, optics, nanotechnology, computing and product design.